Table 7 Spearman’s correlations of serum and urine concentrations of trimethylamine N-oxide (TMAO) and 1-methylhistidine (1-MeHis) with gut microbiota combined for Cod group, Salmon group and Control group, showing only correlations where at least one bacterial probe is significantly correlated with TMAO or 1-MeHis
Counts | Serum (µmol/l) | Urine (µmol/mmol creatinine) | ||
|---|---|---|---|---|
TMAO | 1-MeHis | TMAO | 1-MeHis | |
Baseline | ||||
Akkermansia muciniphila | 0.416* | 0.366* | 0.375* | 0.084 |
Bacteroides sp. | 0.200 | − 0.068 | 0.372* | − 0.066 |
Clostridium methylpentosum | − 0.350* | 0.096 | − 0.073 | 0.218 |
Coprobacillus_cateniformis | 0.229 | − 0.085 | 0.047 | − 0.011 |
Eubacterium rectale | − 0.115 | 0.086 | − 0.071 | 0.141 |
Lachnosp Incertae Sedis | − 0.186 | 0.382* | − 0.127 | 0.331 |
Mycoplasma hominis | 0.253 | 0.100 | 0.298 | 0.232 |
Phascolarctobacterium faecium | 0.129 | 0.437* | 0.212 | 0.222 |
Proteobacteria | 0.201 | 0.166 | 0.358* | 0.064 |
Staphylococcus epidermidis | − 0.213 | 0.125 | − 0.294 | 0.136 |
Streptococcus agalactiae | − 0.297 | − 0.117 | − 0.148 | 0.085 |
Endpoint | ||||
Akkermansia muciniphila | 0.306 | − 0.022 | − 0.142 | − 0.106 |
Bacteroides sp. | − 0.128 | 0.103 | − 0.417* | − 0.087 |
Clostridium methylpentosum | 0.135 | − 0.077 | 0.106 | − 0.097 |
Coprobacillus cateniformis | − 0.025 | − 0.079 | − 0.163 | − 0.415* |
Eubacterium rectale | − 0.130 | − 0.384* | − 0.286 | − 0.482** |
Lachnosp Incertae Sedis | − 0.059 | − 0.214 | − 0.265 | − 0.338 |
Mycoplasma hominis | 0.080 | 0.151 | − 0.040 | 0.371* |
Phascolarctobacterium faecium | 0.201 | 0.272 | − 0.223 | − 0.216 |
Proteobacteria | 0.089 | − 0.062 | 0.126 | 0.034 |
Staphylococcus epidermidis | − 0.121 | − 0.321 | − 0.307 | − 0.364* |
Streptococcus agalactiae | − 0.233 | − 0.310 | − 0.282 | − 0.513** |